AstraZeneca covid vaccine linked to another fatal blood clotting disorder
New Delhi: Researchers have found a link between the AstraZeneca Covid-19 vaccine and a rare but fatal blood clotting disorder. The disorder, known as vaccine-induced immune thrombocytopenia and thrombosis (VITT), has been associated with the AstraZeneca vaccine. A study from Flinders University in Australia and other international experts found that the antibodies responsible for VITT share identical molecular fingerprints with those found in cases of classic adenoviral vector VITT.
These findings have significant implications for vaccine safety and development, as lessons learned from VITT could be applicable to rare cases of blood clotting after adenovirus infections. AstraZeneca has acknowledged the rare side effects of its vaccine, including thrombotic thrombocytopenic syndrome (TTS), and has withdrawn marketing authorization from several global markets.
AstraZeneca's Covid-19 vaccine, known as Covishield in India and Vaxzevria in Europe, has been under scrutiny for its potential side effects. The study highlights the importance of understanding the mechanisms behind rare side effects of vaccines to enhance safety protocols and inform future vaccine development.
Healthcare authorities may need to reassess the risk-benefit profile of the AstraZeneca vaccine, especially in populations prone to rare blood clotting disorders. Continued research into the safety and efficacy of Covid-19 vaccines remains crucial for global vaccination efforts and public health protection.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Ordinance issued to increase number of Supreme Court judges from 34 to 38
New Delhi (PTI): The government has promulgated an ordinance to increase the strength of the Supreme Court from the present 34 judges to 38, including the Chief Justice of India.
The law ministry notified the ordinance on Saturday, which amended the Supreme Court (Number of Judges) Act, 1956, to increase the sanctioned strength of the top court.
So far, the sanctioned strength of the top court was 34, including the Chief Justice of India (CJI). Now, the number of judges has been increased by four, taking the sanctioned strength to 38.
The top court will now have 37 judges, other than the CJI.
With the apex court having two vacancies at present, and the ordinance coming into force immediately, the Supreme Court Collegium will now have to recommend six names for appointment as judges in the top court.
A bill will be brought in the Monsoon Session of Parliament to convert the ordinance – an executive order – into a law passed by Parliament.
The Union Cabinet had cleared a draft bill on May 5 to increase the number of apex court judges.
The strength of the Supreme Court was last increased from 30 to 33 (excluding the CJI) in 2019.
The Supreme Court (Number of Judges) Act, as originally enacted in 1956, put the maximum number of judges (excluding the CJI) at 10.
This number was increased to 13 by the Supreme Court (Number of Judges), Amendment Act, 1960, and to 17 by another amendment to the law.
The Supreme Court (Number of Judges) Amendment Act, 1986, augmented the strength of judges from 17 to 25, excluding the CJI.
A fresh amendment in 2009 further increased the strength from 25 to 30.
Article 124(3) of the Constitution lists the qualifications required to become a Supreme Court judge.
An Indian citizen who has either served as a high court judge for at least five years, or as an advocate for 10 years, or is a distinguished jurist, can be appointed to the top court.
The strength of the Supreme Court is increased based on the recommendations of the CJI, who writes to the Union law minister. After consulting the finance ministry, the Department of Justice under the law ministry moves the Cabinet with a draft bill.
